Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity
暂无分享,去创建一个
[1] A. Gershon,et al. Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study , 2008, European Neuropsychopharmacology.
[2] J. Warren. Synaptic Self: How our Brains Become who we Are , 2002 .
[3] S. Rossi,et al. Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. , 2010, The international journal of neuropsychopharmacology.
[4] Michael Davis,et al. The role of the amygdala in fear and anxiety. , 1992, Annual review of neuroscience.
[5] E. Hollander,et al. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. , 2011, The Journal of clinical psychiatry.
[6] L. Koran,et al. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial. , 2002, The Journal of clinical psychiatry.
[7] L. Koran,et al. Pulse-Loaded Intravenous Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder , 2006, Journal of clinical psychopharmacology.
[8] Sarah H Lisanby,et al. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). , 2005, The international journal of neuropsychopharmacology.
[9] E. Hollander,et al. Treatment non-response in OCD: methodological issues and operational definitions. , 2002, The international journal of neuropsychopharmacology.
[10] T. Endrass,et al. Approach and avoidance learning in obsessive–compulsive disorder , 2011, Depression and anxiety.
[11] E. Hollander,et al. A review of pharmacologic treatments for obsessive-compulsive disorder. , 2003, Psychiatric services.
[12] S. Praharaj,et al. Adjunctive high-frequency right prefrontal repetitive transcranial magnetic stimulation (rTMS) was not effective in obsessive-compulsive disorder but improved secondary depression. , 2010, Journal of anxiety disorders.
[13] P. Mitchell,et al. Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. , 2001, The Journal of clinical psychiatry.
[14] R. Frost,et al. Cognitive approaches to obsessions and compulsions : theory, assessment, and treatment , 2002 .
[15] P. Lichtenstein,et al. Population-based, multigenerational family clustering study of obsessive-compulsive disorder. , 2013, JAMA psychiatry.
[16] J. Rabe-Jabłońska,et al. [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.
[17] M. Capecchi. Hox genes and mammalian development. , 1997, Cold Spring Harbor symposia on quantitative biology.
[18] D. Woods,et al. How related are hair pulling disorder (trichotillomania) and skin picking disorder? A review of evidence for comorbidity, similarities and shared etiology. , 2012, Clinical psychology review.
[19] H. Westenberg,et al. Dysfunctional Reward Circuitry in Obsessive-Compulsive Disorder , 2011, Biological Psychiatry.
[20] S. Haber,et al. The Reward Circuit: Linking Primate Anatomy and Human Imaging , 2010, Neuropsychopharmacology.
[21] E. Bullmore,et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited , 2008, Neuroscience & Biobehavioral Reviews.
[22] Z. Demetrovics,et al. Association between Novelty Seeking of opiate-dependent patients and the catechol-O-methyltransferase Val(158)Met polymorphism. , 2010, Comprehensive psychiatry.
[23] S. Starkstein,et al. A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[24] Christian Kaufmann,et al. Fronto-striato-limbic hyperactivation in obsessive-compulsive disorder during individually tailored symptom provocation. , 2010, Psychophysiology.
[25] J. Mazziotta,et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. , 1988, The American journal of psychiatry.
[26] K. Namkoong,et al. A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessive-compulsive disorder. , 2009, The Journal of clinical psychiatry.
[27] Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial. , 2009, Psychopharmacology bulletin.
[28] Dick J. Veltman,et al. Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography , 2004, Psychiatry Research: Neuroimaging.
[29] J. Zohar,et al. Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder , 2011, CNS drugs.
[30] Frank H. Burton,et al. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive–compulsive disorder , 2000, Brain Research.
[31] Frank H. Burton,et al. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry , 2002, Molecular Psychiatry.
[32] C. Beaulieu,et al. The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.
[33] E. Hollander,et al. FDG-PET Study in Pathological Gamblers , 2008, Neuropsychobiology.
[34] G. Grassi,et al. Obsessive–Compulsive Disorder Comorbidity: Clinical Assessment and Therapeutic Implications , 2011, Front. Psychiatry.
[35] B. Harrison,et al. Altered Cortico-Striatal Functional Connectivity in Obsessive-Compulsive Disorder , 2009, NeuroImage.
[36] J. Rapoport,et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. , 1989, Archives of general psychiatry.
[37] K. Phillips,et al. Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine. , 1999, Psychosomatics.
[38] D. Sookman,et al. Overestimation of Threat and Intolerance of Uncertainty in Obsessive Compulsive Disorder , 2002 .
[39] L. Lange,et al. Sweet liking and high novelty seeking: independent phenotypes associated with alcohol-related problems. , 2010, Alcohol and alcoholism.
[40] G. Willemsen,et al. Marital resemblance for obsessive–compulsive, anxious and depressive symptoms in a population-based sample , 2008, Psychological Medicine.
[41] L. Koran,et al. Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. , 2005, The Journal of clinical psychiatry.
[42] Michael E Phelps,et al. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder , 1998, Psychiatry Research: Neuroimaging.
[43] E. Storch,et al. DIFFICULT‐TO‐TREAT PEDIATRIC OBSESSIVE‐COMPULSIVE DISORDER: FEASIBILITY AND PRELIMINARY RESULTS OF A RANDOMIZED PILOT TRIAL OF d‐CYCLOSERINE‐AUGMENTED BEHAVIOR THERAPY , 2013, Depression and anxiety.
[44] Kamryn T. Eddy,et al. Amygdala-frontal connectivity during emotion regulation. , 2007, Social cognitive and affective neuroscience.
[45] Long-Term Follow-Up Study of Patients With Refractory Obsessive-Compulsive Disorder , 2008 .
[46] S. Akhondzadeh,et al. Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder , 2012, CNS Drugs.
[47] E. Smeraldi,et al. Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation. , 2009, Primary care companion to the Journal of clinical psychiatry.
[48] A Ahonen,et al. Dopamine Transporter Density and Novelty Seeking Among Alcoholics , 2001, Journal of addictive diseases.
[49] R. Goldstein,et al. The demography, phenomenology, and family history of 22 persons with compulsive hair pulling. , 1994, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[50] P. Whalen,et al. The Structural Integrity of an Amygdala–Prefrontal Pathway Predicts Trait Anxiety , 2009, The Journal of Neuroscience.
[51] T. Insel,et al. Toward a neuroanatomy of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.
[52] M. Pompili,et al. Functional Neuroimaging in Obsessive-Compulsive Disorder , 2011, Neuropsychobiology.
[53] J. Thome,et al. Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology , 2003, Journal of Neural Transmission.
[54] E. Aboujaoude,et al. Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: An Open-Label Trial , 2009, Journal of clinical psychopharmacology.
[55] D. Belin,et al. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: A review , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[56] E. Hollander,et al. Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder , 2009, CNS drugs.
[57] R. Baldessarini,et al. Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both , 2006, Human psychopharmacology.
[58] J. McGeary,et al. GENETIC STUDY: The dopamine D4 Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects , 2009 .
[59] Kent A. Kiehl,et al. Dysfunctional Action Monitoring Hyperactivates Frontal–striatal Circuits in Obsessive–compulsive Disorder: an Event-related Fmri Study , 2004 .
[60] Michael B. First,et al. A Research Agenda for DSM-V , 2002 .
[61] Thomas J. H. Chen,et al. The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors , 2000, Journal of psychoactive drugs.
[62] D. Murphy,et al. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. , 1997, The American journal of psychiatry.
[63] Darin D Dougherty,et al. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder , 2001, Biological Psychiatry.
[64] A Ahonen,et al. The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics. , 2001, Alcohol and alcoholism.
[65] J. Pujol,et al. Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. , 2001, The American journal of psychiatry.
[66] Tommy Pattij,et al. Dopamine receptor D1/D5 gene expression in the medial prefrontal cortex predicts impulsive choice in rats. , 2010, Cerebral cortex.
[67] W. Gehring,et al. Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder , 2005, Biological Psychiatry.
[68] C. Pittenger,et al. Systematic Review: Pharmacological and Behavioral Treatment for Trichotillomania , 2007, Biological Psychiatry.
[69] S. Dulawa,et al. Essential Role for Orbitofrontal Serotonin 1B Receptors in Obsessive-Compulsive Disorder-Like Behavior and Serotonin Reuptake Inhibitor Response in Mice , 2011, Biological Psychiatry.
[70] Steven C. R. Williams,et al. Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers , 2003, Biological Psychiatry.
[71] G. Feng,et al. Sapap3 Deletion Causes mGluR5-Dependent Silencing of AMPAR Synapses , 2011, The Journal of Neuroscience.
[72] H. Uylings,et al. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. , 2006, Archives of general psychiatry.
[73] Y. Janardhan Reddy,et al. DRD4 gene and obsessive compulsive disorder: Do symptom dimensions have specific genetic correlates? , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[74] Kristen K. Ade,et al. Circuit-Selective Striatal Synaptic Dysfunction in the Sapap3 Knockout Mouse Model of Obsessive-Compulsive Disorder , 2013, Biological Psychiatry.
[75] Shahin Rafii,et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice , 2010, Nature Medicine.
[76] Petr Tvrdik,et al. Hematopoietic Origin of Pathological Grooming in Hoxb8 Mutant Mice , 2010, Cell.
[77] M. Kringelbach. The human orbitofrontal cortex: linking reward to hedonic experience , 2005, Nature Reviews Neuroscience.
[78] A. Ibáñez,et al. The extended fronto-striatal model of obsessive compulsive disorder: convergence from event-related potentials, neuropsychology and neuroimaging , 2012, Front. Hum. Neurosci..
[79] M. Caron,et al. OCD-Like Behaviors Caused by a Neuropotentiating Transgene Targeted to Cortical and Limbic D1+ Neurons , 1999, The Journal of Neuroscience.
[80] Sarah H. Lisanby,et al. Functional Magnetic Resonance Imaging Guided Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder , 2010, Biological Psychiatry.
[81] L. Kegeles,et al. Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept , 2013, Neuropsychopharmacology.
[82] Z. Tunca,et al. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression , 2001, Psychiatry Research: Neuroimaging.
[83] A. Sahraian,et al. Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial , 2010, CNS Spectrums.
[84] D. Murphy,et al. Phenomenological features and clinical impact of affective disorders in OCD: a focus on the bipolar disorder and ocd connection , 2012, Depression and anxiety.
[85] R. Depue,et al. Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion , 1999, Behavioral and Brain Sciences.
[86] T. Robbins,et al. Orbitofrontal Dysfunction in Patients with Obsessive-Compulsive Disorder and Their Unaffected Relatives , 2008, Science.
[87] A L Brody,et al. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder , 1998, British Journal of Psychiatry.
[88] T. Hendler,et al. Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD , 2003, Psychiatry Research: Neuroimaging.
[89] M. Potenza,et al. Addicted to Hair Pulling? How an Alternate Model of Trichotillomania May Improve Treatment Outcome , 2007, Harvard review of psychiatry.
[90] Robert T. Rubin,et al. Psychopharmacology: The Fourth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology , 1996 .
[91] E. Storch,et al. Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale. , 2010, Psychological assessment.
[92] Erik Woody,et al. Obsessive-compulsive disorder as a disturbance of security motivation. , 2004, Psychological review.
[93] S. E. Stewart,et al. Meta‐analysis of association between obsessive‐compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1 , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[94] B. Aouizerate,et al. Pathophysiology of obsessive–compulsive disorder A necessary link between phenomenology, neuropsychology, imagery and physiology , 2004, Progress in Neurobiology.
[95] Dan J Stein. Advances in understanding the anxiety disorders: the cognitive-affective neuroscience of 'false alarms'. , 2006, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[96] John Suckling,et al. White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. , 2008, The American journal of psychiatry.
[97] S. Rauch,et al. Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. , 2003, Psychopharmacology bulletin.
[98] D. Stein,et al. Cluster analysis of obsessive-compulsive symptomatology: identifying obsessive-compulsive disorder subtypes. , 2008, The Israel journal of psychiatry and related sciences.
[99] L. Koran,et al. Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. , 2009, The Journal of clinical psychiatry.
[100] S. Dudek,et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice , 2007, Nature.
[101] Joseph M. Antony. Grooming and Growing with Microglia , 2010, Science Signaling.
[102] S. Rauch,et al. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways , 2012, Trends in Cognitive Sciences.
[103] Y Wang,et al. Genome-wide association study of obsessive-compulsive disorder , 2013, Molecular Psychiatry.
[104] M. Bareš,et al. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. , 2006, Neuro endocrinology letters.
[105] S. Rauch,et al. Neurobiology of emotion perception II: implications for major psychiatric disorders , 2003, Biological Psychiatry.
[106] S. Saxena. Pharmacotherapy of compulsive hoarding. , 2011, Journal of clinical psychology.
[107] E. Hollander,et al. A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder. , 2004, The Journal of clinical psychiatry.
[108] W. Ecker,et al. Incompleteness as a link between obsessive-compulsive personality traits and specific symptom dimensions of obsessive-compulsive disorder. , 2014, Clinical psychology & psychotherapy.
[109] N. Fineberg,et al. Evidence-based treatment pathways for translational studies in obsessive-compulsive disorders. , 2013, Modern trends in pharmacopsychiatry.
[110] S. Rauch,et al. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. , 2000, The Psychiatric clinics of North America.
[111] P. Mitchell,et al. Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation , 2007, Psychological Medicine.
[112] M. Hirschtritt,et al. An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. , 2007, Journal of child and adolescent psychopharmacology.
[113] J. Greer,et al. Hoxb8 Is Required for Normal Grooming Behavior in Mice , 2002, Neuron.
[114] Citalopram Pulse-Loading for Severe Treatment-Resistant OCD: A Case Series of Acute Response, One Year Follow-Up and Tolerability , 2013 .